Crizotinib is used to treat non-small cell lung cancer. The drug inhibits anaplastic lymphoma kinase by competing for the ATP-binding site of the enzyme. Crizotinib is also in clinical trials for the treatment of disseminated anaplastic large-cell lymphoma and neuroblastoma. | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Science Source / Greg Williams |
Taille de l’image : | 6600 px × 3900 px |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : | - |